Q3 FY2026 · ended Sep 30, 2026 · Revenue $33.60M, +14.2% YoY · Filed Nov 4, 2026
Outset Medical, Inc. (OM) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $33.6 million and a net loss of $14.7 million. Free cash flow was -$10.5 million. As of Sep 30, 2026 it held $136.6 million in cash and investments and $104.8 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- OM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1484612
- Former names
- Home Dialysis Plus, Ltd. (until Feb 25, 2011)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $33.6M | $31.6M | $27.9M | $28.9M | $29.4M |
| Operating income | -$12.3M | -$15.7M | -$16.9M | -$17.6M | -$15.8M |
| Net income | -$14.7M | -$18.0M | -$19.0M | -$19.5M | -$17.8M |
| Diluted EPS | -$0.78 | -$0.97 | -$1.03 | -$1,075.82 | -$1.00 |
| Operating cash flow | -$10.4M | -$9.6M | -$12.8M | -$9.5M | -$6.3M |
| Free cash flow | -$10.5M | -$9.7M | -$12.9M | -$9.7M | -$6.5M |
| Total assets | $230.4M | $242.4M | $249.5M | $264.5M | $277.3M |
| Total liabilities | $147.1M | $146.0M | $137.8M | $137.5M | $134.9M |
| Stockholders' equity | $83.3M | $96.3M | $111.7M | $127.0M | $142.4M |
| Cash and investments | $136.6M | $147.2M | $156.7M | $168.9M | $178.6M |
| Total debt | $104.8M | $104.4M | $101.6M | $101.2M | $98.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Jun 17, 2026 | Jun 14, 2026 |
All 743 Outset Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.